- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2524-4426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Overcoming the limitations of locally administered oncolytic virotherapy ; volume:1 ; number:1 ; day:1 ; month:7 ; year:2019 ; pages:1-11 ; date:12.2019
BMC biomedical engineering ; 1, Heft 1 (1.7.2019), 1-11, 12.2019
- Urheber
-
Hong, JinWoo
Yun, Chae-Ok
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s42490-019-0016-x
- URN
-
urn:nbn:de:101:1-2019091110405404945948
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hong, JinWoo
- Yun, Chae-Ok
- SpringerLink (Online service)
Ähnliche Objekte (12)
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Key parameters of measles virus production for oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
Combining Oncolytic Virotherapy with Target Therapy in Bladder Cancer
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Key parameters of measles virus production for oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
Combining Oncolytic Virotherapy with Target Therapy in Bladder Cancer
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Key parameters of measles virus production for oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy